Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Chris Degnan

CFO at UroGen Pharma Ltd. (URGN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $118K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 9SEC URGNUroGen Pharma Ltd. Sell 2,2024,561 held (−33%) $36.69 $81K -5.8%
Oct 9SEC URGNUroGen Pharma Ltd. Sell 2,2032,280 held (−49%) $16.85 $37K +105.1%
  • Sell

    CFO Chris Degnan sold $81K of URGN at $36.69 — cuts the stake by 33%.

  • Sell

    CFO Chris Degnan sold $37K of URGN at $16.85 — cuts the stake by 49%.